DDW_Azenta_Event_Logo_400px copy
Azenta_webinar_panellist_images copy

AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. 

In this webinar, hosted by DDW and supported by Azenta Life Sciences, we'll help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development.

What you will learn:

  • How to optimise AAV plasmid preparation
    Best practices to address unstable sequencing
  • Solutions for viral packaging, storage, and indexing
  • Selecting purity and fidelity assays
  • Bioinformatics tools for interpreting complex 
  • GLP sequencing confirmation solutions

    Watch the webinar on-demand now!

Watch the Webinar